Mark Griffiths

Dishman Pharmaceuticals & Chemicals Ltd. manufactures and markets drugs, intermediates, fine chemicals and quats. It operates through the following business segments: Contract Research & Manufacturing and Others. The Contract Research & Manufacturing segment develops intermediates and active pharmaceutical ingredients. The others segment trades in bulk drugs, intermediates, quats, specialty chemicals and outsourced goods. The company was founded on June 29, 1983 and is headquartered in Ahmedabad, India.

CARBOGEN AMCIS AG provides solutions for the development and supply of drug substances as well as drug products to the pharmaceutical and biopharmaceutical industries. It offers services such as process research, process optimization, formulation, supply of pharmaceutical intermediates, active pharmaceutical ingredients manufacturing, project management, and safety. The company was founded in 2006 and is headquartered in Bubendorf, Switzerland.

Carbogen Amcis (India) Ltd. engages in the manufacture of bulk drugs. It operates through Contract Research and Contract Manufacturing, and Bulk Drugs, Intermediates, Quats, Specialty Chemicals and Traded Goods segments. It offers a portfolio of drug development, and commercialization services to pharmaceutical industry at all stages of new drug development. The company was founded on July 17, 2007 and is headquartered in

Part of Adimans Technologies LLP, Dishman Netherlands BV is a Dutch innovative company dedicated to the re-use of critical raw materials. The company successfully developed a market study for the EU funded REECOVER project, focused on the re-use of rare earths from electronic waste and mine tailings. Currently, in the EU funded ICARUS project, Dishman Netherlands is responsible for market studies, IPR management, and the exploitation process of the technologies that are being developed to recycle silicon kerf, graphite, and silica. The company's current trade business activities consist of the trade in triphenyl phosphine oxide (Tppo), which has been one of the company's activities for more than 20 years, with large multinational companies as its main clients.

Part of Adimans Technologies LLP, Dishman Pharma Solutions AG is a Swiss company that manufactures and processes drugs. The company is based in Bubendorf, Switzerland.